[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354349-105":59,"doc-detail-354349-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","decoding-glioblastoma-complexity-through-extracellular-vesicles-organ-on-chip-models-and-deep-learning","Decoding Glioblastoma Complexity Through Extracellular Vesicles, Organ-on-Chip Models, and Deep Learning","","Glioblastoma (GBM) is an extremely aggressive cancer marked by therapeutic failure driven by intratumoral heterogeneity, microenvironment plasticity, immune suppression, blood–brain barrier (BBB) pharmacological constraints, and adaptive resistance. A key challenge in GBM research is the absence of human-relevant experimental systems that reproduce these dynamic features while providing interpretable, multimodal data. This work proposes an organ-on-chip–extracellular vesicle–deep learning framework for linking EV-mediated communication to measurable phenotypes and outlines critical technical, data, and translational considerations.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/decoding-glioblastoma-complexity-through-extracellular-vesicles-organ-on-chip-models-and-deep-learning/354349/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/decoding-glioblastoma-complexity-through-extracellular-vesicles-organ-on-chip-models-and-deep-learning/354349.png","ImageObject",300,407,{"name":92,"@type":93},"4398046744996","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What key problem does this work address in glioblastoma research?","Question",{"text":112,"@type":113},"It addresses the lack of a human-relevant experimental system that can reproduce GBM’s dynamic intratumoral and microenvironmental features while generating interpretable, multimodal datasets.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does the proposed framework integrate extracellular vesicles with organ-on-chip systems and deep learning?",{"text":117,"@type":113},"Patient-derived cells are organized in perfused microphysiological organ-on-chip models, EVs are selectively and temporally harvested from defined compartments, and imaging and functional readouts are fused through modality-specific and multimodal deep learning architectures.",{"name":119,"@type":110,"acceptedAnswer":120},"Which GBM-related outcomes does the framework aim to connect to measurable phenotypes?",{"text":121,"@type":113},"It targets phenotypes such as BBB disruption, invasion, immune reprogramming, and drug response, positioning the approach as a staged translational roadmap rather than an immediately validated clinical tool.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},354349,1790917463,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":66,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":133,"file_id":134,"file_url":135,"file_type":136,"file_size":137,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":138,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},4398046744996,"Perspective  \nDecoding Glioblastoma Complexity Through Extracellular Vesicles, Organ-on-Chip Models, and Deep Learning  \nDomenico Amato 1,†, Giuseppa D’Amico 2,†, Salvatore Calderaro 1,3, Alessandra Maria Vitale 2,4,  \nPierlorenzo Veiceschi 2,5, Francesco Cappello 2,4, Celeste Caruso Bavisotto 2,4, * and Giosuè Lo Bosco 1,4, *  \nAcademic Editor: Pablo Martín-Vasallo  \nReceived: 30 April 2026  \nRevised: 8 June 2026  \nAccepted: 12 June 2026  \nPublished: 14 June 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Mathematics and Computer Science, University of Palermo, Via Archirafi 34,  \n90123 Palermo, Italy; [domenico.amato01@unipa.it](domenico.amato01@unipa.it) (D.A.); [salvatore.calderaro01@unipa.it](salvatore.calderaro01@unipa.it) (S.C.)  \n2 Section of Human Anatomy and Histology, Department of Biomedicine, Neuroscience and Advanced Diagnostics (BIND), University of Palermo, Via del Vespro 129, 90127 Palermo, Italy; [giuseppa.damico01@unipa.it](giuseppa.damico01@unipa.it) (G.D.); alessandramaria.vitale@unipa.it (A.M.V.); [pierlorenzomaria.veiceschi@unipa.it](pierlorenzomaria.veiceschi@unipa.it) (P.V.); [francesco.cappello@unipa.it](francesco.cappello@unipa.it) (F.C.)  \n3 Department of Physics and Chemistry, University of Palermo, Via Archirafi 36, 90123 Palermo, Italy  \n4 Euro-Mediterranean Institute of Science and Technology (IEMEST), Via Michele Miraglia, 90139 Palermo, Italy  \n5 Department of Neurosurgery, National Relevance and High Specialization Hospital Trust ARNAS Civico, 90127 Palermo, Italy  \n* Correspondence: [celeste.carusobavisotto@unipa.it](celeste.carusobavisotto@unipa.it) (C.C.B.); [giosue.lobosco@unipa.it](giosue.lobosco@unipa.it) (G.L.B.)† These authors contributed equally to this work.  \nAbstract  \nGlioblastoma (GBM) is one of the most aggressive human cancers, with therapeutic failure driven by pronounced intratumoral heterogeneity, microenvironmental plasticity, immune suppression, blood–brain barrier (BBB)-related pharmacological constraints, and adaptive resistance mechanisms. A major limitation in GBM research is the lack of a humanrelevant experimental system able to reproduce these dynamic features while generating interpretable, multimodal datasets. In this context, we propose a testable organ-on-chip (OoC)-extracellular vesicle (EV)-deep learning (DL) framework in which patient-derived GBM cells, endothelial cells, astrocytes, pericytes, stromal cells, and immune components are organized within perfused microphysiological systems. EVs are selectively and temporally harvested from defined compartments, and imaging, barrier-function, sensor, and EV-cargo data are integrated through modality-specific and multimodal DL architectures. This framework is intended not as an immediately validated clinical tool but as an experimental roadmap for linking EV-mediated communication to measurable phenotypes such as BBB disruption, invasion, immune reprogramming, and drug response. We critically discuss the technical requirements of BBB-on-chip systems, EV source attribution, immune-component integration, DL model selection, data scarcity, overfitting, batch effects, domain shift, regulatory barriers, cost, throughput, and reproducibility. By repositioning OoC-EV-DL integration as a staged translational strategy rather than a clinically established solution, this work aims to define a realistic and biologically grounded route for advancing precision oncology in GBM.  \nKeywords: glioblastoma; extracellular vesicles; exosomes; organ-on-chip; tumor microenvironment; blood–brain barrier; deep learning; microfluidics; 3D in vitro models; precision oncology  \n1. Introduction: The Need for Innovation in Glioblastoma (GBM) Research  \nGBM is the most aggressive and malignant primary brain tumor in adults. It is characterized by rapid growth, brain","cbCaidIbOeD4weAu","https://ap.wps.com/l/cbCaidIbOeD4weAu","pdf",1060288,17,"English","# Abstract\n# Keywords\n# 1. Introduction: The Need for Innovation in Glioblastoma (GBM) Research\n## GBM characteristics and standard-of-care outcomes\n## Drivers of resistance: stem cells and immunosuppressive TME\n## Limitations of conventional 2D models\n## Advantages and emergence of 3D models","[{\"question\":\"What key problem does this work address in glioblastoma research?\",\"answer\":\"It addresses the lack of a human-relevant experimental system that can reproduce GBM’s dynamic intratumoral and microenvironmental features while generating interpretable, multimodal datasets.\"},{\"question\":\"How does the proposed framework integrate extracellular vesicles with organ-on-chip systems and deep learning?\",\"answer\":\"Patient-derived cells are organized in perfused microphysiological organ-on-chip models, EVs are selectively and temporally harvested from defined compartments, and imaging and functional readouts are fused through modality-specific and multimodal deep learning architectures.\"},{\"question\":\"Which GBM-related outcomes does the framework aim to connect to measurable phenotypes?\",\"answer\":\"It targets phenotypes such as BBB disruption, invasion, immune reprogramming, and drug response, positioning the approach as a staged translational roadmap rather than an immediately validated clinical tool.\"}]","Decoding Glioblastoma Complexity Through Extracellular Vesicles, Organ-on-Chip Models, and Deep Learning | PDF",1790110231,43,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2f7305dfd707cb7b9b9e87025fc4e0c6.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8197a53ea7b3e96a4e6366475ac600b9.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7d6bbb79e9dcbbd22cbd8e94177afa29.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d01789b47ed542c9e05fb341bfa51fb6.webp",980,1385]